Board Change • May 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. MD, CEO & Executive Director Glenn Corrie was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Annonce • Oct 24
Energypathways plc Commences Technological-Commercial Studies with Hazer Group Limited in Relation to Graphite Production from Its Planned Mesh Project EnergyPathways announced that it is commencing techno-commercial studies with Hazer Group Limited ("Hazer") in relation to graphite production from its planned MESH project ("MESH"). High grade synthetic graphite will be produced as a by-product from the MESH low-carbon hydrogen production facility to be located in Barrow-in Furness. Graphite has been identified by a number of countries, including the UK, as a critical mineral to meet their net zero ambitions. The Company's potential future graphite production may provide the Company with a major additional revenue stream. In July 2025, EnergyPathways entered into a strategic engagement and MOU with Hazer, a global leader in methane pyrolysis hydrogen production, licensed worldwide through its alliance with KBR Inc. Under the agreement, EnergyPathways holds the exclusive rights to deploy Hazer's hydrogen and graphite production technology in the UK, providing a strong competitive advantage in one of the most strategically important sectors of the clean energy transition. Importantly, Hazer also has a strategic partnership with Mitsui & Co. Ltd. ("Mitsui") to explore and develop markets for Hazer graphite, which is targeting a range of potential applications, including high-end uses across the battery, anode and advanced materials sectors. This partnership positions EnergyPathways to leverage premium market access and offtake opportunities across the UK, EU and globally as the MESH project progresses towards development. Mitsui is a blue chip company with a market capitalisation of around PS56 billion. High-Impact MESH Project: Clean Hydrogen and Battery-Grade Graphite The Hazer-KBR technology converts natural gas into low-carbon hydrogen and high-purity synthetic graphite with no CO2 emissions, establishing a game-changing decarbonisation pathway for industrial hydrogen production and critical mineral supply. The MESH facility is designed to deliver: 90 MW of low-carbon hydrogen production capacity (~20,000 tonnes per annum); Up to 60,000 tonnes per annum of synthetic graphite with an initial 95% purity, with potential to upgrade to >99.9% This dual-output model offers compelling economics and diversified revenue streams in two high-growth, government-backed sectors of clean hydrogen and battery materials. Recently, battery-grade synthetic graphite prices have exceeded as much as USD 10,000 per tonne, more than 120% higher than pre-pandemic levels, reflecting tightening supply and strong demand from the EV and energy storage sectors. The Hazer technology is currently attracting strong inbound interest from global battery, anode and materials manufacturers, underscoring its strategic relevance and scalability in emerging energy markets. The Company has the exclusive right to deploy Hazer low-carbon hydrogen and graphite production technology In the UK. This positions MESH as a potential major producer and supplier of high quality and battery grade graphite that can meet the UK's growing demand for this critical mineral in energy transition. MESH's potential graphite production capability can play an important part in shoring up the UK's energy security and its critical minerals supply chain. The MESH system is designed to capture and store curtailed offshore wind power in offshore salt caverns as compressed air. The MESH energy storage system combines associated large-scale hydrogen, thermal and natural gas storage capacity in geo-storage features (the salt caverns). During periods of low renewable energy availability, the LDES stored energy storage capacity (the LDES stored energy storage capacity in the UK and Europe). Annonce • Sep 24
Hazer Group Limited, Annual General Meeting, Nov 18, 2025 Hazer Group Limited, Annual General Meeting, Nov 18, 2025. Location: at level 37, 180 george street, nsw 2000., sydney Australia Annonce • Jun 18
Hazer Group Limited has completed a Follow-on Equity Offering in the amount of AUD 8 million. Hazer Group Limited has completed a Follow-on Equity Offering in the amount of AUD 8 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 22,580,645
Price\Range: AUD 0.31
Discount Per Security: AUD 0.0186
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 3,225,806
Price\Range: AUD 0.31
Discount Per Security: AUD 0.0186
Transaction Features: Subsequent Direct Listing Annonce • Jun 16
Hazer Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Hazer Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,451,613
Price\Range: AUD 0.31 New Risk • Sep 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$23m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.9m net loss in 3 years). Shareholders have been diluted in the past year (15% increase in shares outstanding). Revenue is less than US$5m (AU$3.3m revenue, or US$2.3m). Market cap is less than US$100m (€52.2m market cap, or US$58.1m). Annonce • Sep 25
Hazer Group Limited, Annual General Meeting, Nov 20, 2024 Hazer Group Limited, Annual General Meeting, Nov 20, 2024. Location: at level 39, central park building, 152-158 st georges terrace, perth wa 6000 Australia Board Change • Sep 08
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Tim Goldsmith was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 30
Full year 2024 earnings released: AU$0.093 loss per share (vs AU$0.072 loss in FY 2023) Full year 2024 results: AU$0.093 loss per share (further deteriorated from AU$0.072 loss in FY 2023). Revenue: AU$3.79m (up 58% from FY 2023). Net loss: AU$19.1m (loss widened 56% from FY 2023). Revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings. New Risk • Jul 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$6.8m net loss in 3 years). Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (35% increase in shares outstanding). Revenue is less than US$5m (AU$2.8m revenue, or US$1.9m). Market cap is less than US$100m (€53.7m market cap, or US$58.2m). New Risk • Feb 25
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$12m net loss in 2 years). Share price has been volatile over the past 3 months (9.1% average weekly change). Shareholders have been diluted in the past year (29% increase in shares outstanding). Revenue is less than US$5m (AU$2.4m revenue, or US$1.6m). Market cap is less than US$100m (€64.4m market cap, or US$69.7m). Annonce • Dec 02
Hazer Group Ltd Announces the Appointment of Joan Dabon as Company Secretary Hazer Group Ltd. announced the appointment of Ms Joan Dabon as company secretary to the Company, effective 1 December 2023. Ms Dabon is a Chartered Secretary with Source Governance and has over 7 years' experience in providing company secretarial and corporate advisory services to ASX and NSX listed companies across a variety of sectors including mining, property development, logistics and distribution, consumer services, manufacturing, and agriculture. She has also acted as company secretary for public unlisted and proprietary companies, monitoring and managing their corporate governance and compliance frameworks. Ms Dabon has Juris Doctor degree and is an associate member of the Governance Institute of Australia. Ms Dabon replaces Mr. Harry Spindler who resigned to pursue other professional opportunities. The Board would like to thank Mr. Spindler for his contribution and services and wish him all the best in his future endeavours. Annonce • Oct 05
Hazer Group Limited, Annual General Meeting, Nov 23, 2023 Hazer Group Limited, Annual General Meeting, Nov 23, 2023. Agenda: To consider and conduct election of directors. Annonce • Sep 01
Hazer Group Limited Appoints Neil Brodie as Chief Financial Officer Hazer Group Ltd. has appointed Neil Brodie as Chief Financial Officer (CFO) effective 1 September 2023. Mr. Brodie has acted as Hazer Group's Interim CFO since December 2022 and possesses over 25 years of finance, strategic planning, and commercial experience in energy-related industries, including senior roles in the private and public sector. Previously, CFO at the National Offshore Petroleum Safety and Environment Management Agency (NOPSEMA) and Deputy CFO at a green hydrogen startup following an extensive career with Chevron where he held senior finance positions in the LNG and corporate functions internationally. Mr. Brodie is an Associate of the Chartered Institute of Management Accountants (UK), holds a Master of Business Administration from Curtin University and is a Graduate of the Australian Institute of Company Directors. He is also an ESG professional with International Financial Reporting Standards FSA accreditation. Reported Earnings • Aug 23
Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.10 loss in FY 2022) Full year 2023 results: AU$0.072 loss per share (improved from AU$0.10 loss in FY 2022). Revenue: AU$2.40m (up 94% from FY 2022). Net loss: AU$12.2m (loss narrowed 26% from FY 2022). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. New Risk • Aug 22
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 9.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$18m). Share price has been volatile over the past 3 months (7.9% average weekly change). Shareholders have been diluted in the past year (9.9% increase in shares outstanding). Revenue is less than US$5m (AU$1.7m revenue, or US$1.1m). Market cap is less than US$100m (€54.2m market cap, or US$58.8m). Reported Earnings • Feb 26
First half 2023 earnings released: AU$0.029 loss per share (vs AU$0.085 loss in 1H 2022) First half 2023 results: AU$0.029 loss per share (improved from AU$0.085 loss in 1H 2022). Net loss: AU$4.84m (loss narrowed 63% from 1H 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Reported Earnings • Sep 02
Full year 2022 earnings released: AU$0.10 loss per share (vs AU$0.082 loss in FY 2021) Full year 2022 results: AU$0.10 loss per share (down from AU$0.082 loss in FY 2021). Net loss: AU$16.4m (loss widened 41% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Recent Insider Transactions • Jul 19
Independent Non-Executive Chairman recently bought €127k worth of stock On the 15th of July, Timothy Goldsmith bought around 250k shares on-market at roughly €0.51 per share. This was the largest purchase by an insider in the last 3 months. This was Timothy's only on-market trade for the last 12 months. Reported Earnings • Mar 02
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: AU$0.085 loss per share (down from AU$0.013 loss in 1H 2021). Net loss: AU$13.0m (loss widened AU$11.2m from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 75% per year, which means it is well ahead of earnings. Buying Opportunity • Jan 22
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 16%. The fair value is estimated to be AU$0.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. Earnings per share has grown by 35% per annum over the last 3 years. Recent Insider Transactions • Feb 18
CEO, MD & Executive Director recently bought €190k worth of stock On the 9th of February, Geoffrey Ward bought around 198k shares on-market at roughly €0.96 per share. This was the largest purchase by an insider in the last 3 months. This was Geoffrey's only on-market trade for the last 12 months. Recent Insider Transactions • Feb 06
Independent Non-Executive Director recently bought €131k worth of stock On the 28th of January, Danielle Lee bought around 128k shares on-market at roughly €1.02 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Is New 90 Day High Low • Feb 04
New 90-day high: €1.15 The company is up 195% from its price of €0.39 on 06 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. Is New 90 Day High Low • Jan 15
New 90-day high: €0.70 The company is up 80% from its price of €0.39 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. Is New 90 Day High Low • Dec 31
New 90-day high: €0.54 The company is up 74% from its price of €0.31 on 02 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: €0.52 The company is up 120% from its price of €0.23 on 16 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 12
New 90-day high: €0.51 The company is up 152% from its price of €0.20 on 14 July 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Sep 24
New 90-day high: €0.29 The company is up 11% from its price of €0.26 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.